Navigation Links
Elsevier Launches a New Product Literature Database Solution for Life Science Professionals
Date:7/16/2012

AMSTERDAM, July 16, 2012 /PRNewswire/ --

Elsevier, a world-leading provider of scientific, technical, and medical information products and services, today announced the launch of a structured Product Literature Database (PLD) solution for professionals in the life sciences. The PLD solution is a further development of the QUOSA literature management solution and it enables a higher level of scalability, automation and usability. QUOSA, a content management and workflow productivity solutions provider, was acquired by Elsevier in January 2012.

PLDs are centralized repositories of product-related scientific literature maintained by life sciences institutions to meet regulatory reporting requirements, address medical inquiries and inform progress in product development. PLDs are used by a broad array of groups within life science institutions who need to access public information related to their company's and competitor's products. PLDs primarily contain information from journal and conference abstracts as well as some other public sources, for example media articles.

Michael Rai, General Manager of QUOSA at Elsevier, said, "We have recognized content management and workflow productivity to be a key strategic area in life sciences to support. Our new PLD solution both compliments our current content sources like Embase and extends ourselves to better support the workflows of end users in, for example, medical affairs and pharmacovigilance groups. We are actively engaging in end user discussions to help define how we can take the QUOSA key product components and develop superior workflow solutions for improved post market surveillance."

Elsevier has tailored and upgraded QUOSA's solution to serve the specific needs of life sciences professionals such as pharmacovigilance and medical affairs personnel in pharma, biotech and medical device companies. New functionalities include:

  • Outbound email alert setting by end users. Users can set their own alerts on any search or topic area in the PLD, including alert topics created by expert information professionals.
  • Enhanced scalability to support the import of hundreds or thousands of alerts from a range of external sources.
  • Automated tagging of search results for most efficient management of large sets of results.
  • Enhanced search interface including configurable faceted browsing of search results.
  • Saved searches, both personal and public, as permanently available, up-to-date views of the PLD content.

These new features complement existing QUOSA functionality which is also essential to the PLD solution:

  • Copyright-compliant full-text article archive and sharing, with full-text searching.
  • Integration with Copyright Clearance Center's RightSphere® rights advisory tool for visibility of copyright information and for conditioning related actions.
  • Full-text and metadata retrieval from a wide range of sources, including normalization of the related metadata.
  • Customizable metadata for internal value-add and assistance with company workflows.
  • Streamlined end-user access to PDFs.
  • Automated PDF availability checking to minimize document ordering costs.
  • Integration with document delivery systems for acquisition and re-use of purchased PDFs.

Please visit the QUOSA Product Literature Database web page for more information.

About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, MD Consult and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Tom Reller
+1-215-239-3508
T.Reller@elsevier.com


'/>"/>
SOURCE Elsevier
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Elsevier and The Geological Society of London Take Home the 2012 Getenergy Award for Education / Industry Partnership
2. Elsevier Launches New Journal: Learning, Culture and Social Interaction
3. Elsevier Collaborates With Prophecy Healthcare to Enhance Its Staff Development Offerings for Healthcare Organizations
4. Elsevier/Gold Standard Exclusive Publisher of New Predictive Drug Price Type
5. Leading German Researcher Awarded Elseviers 2011 Tetrahedron Prize
6. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
7. Elsevier Acquires QUOSA, Provider of Life Sciences Content Management and Workflow Productivity Solutions
8. Elsevier Foundation Awards 2011 Grants to Advance Women in Science and Support Libraries in Developing Countries
9. Elsevier and Federation of Biochemical Societies Launch New Journal: FEBS Open Bio
10. Elsevier Collaborates with the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)
11. Elsevier / MEDai Appoints Tom Zajac as New President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. ... the development and commercialization of targeted antiviral therapies, announced ... Investor Conference 2016, to be held February 8-9, 2016, ... Group,s 2016 Disruptive Growth & Healthcare Conference, taking place ... 10-11, 2016. James Sapirstein , Chief Executive ...
(Date:2/4/2016)... February 4, 2016 Strasbourg, France ... Inc. --> Strasbourg, France , to ... PharmaVentures is pleased to announce that it acted as ... manufacturing unit in Strasbourg, France , to ... --> --> Transgene (Euronext: TNG), a ...
(Date:2/3/2016)... 3, 2016  With the growing need for ... is underway, therapies such as monoclonal antibodies, recombinant ... host of indications are in high demand. Conventionally ... development and production of these therapeutics. However, due ... high costs, novel approaches and novel expression systems ...
(Date:2/3/2016)... ... February 03, 2016 , ... Aerocom, a world-leading supplier of ... North American healthcare market. , Aerocom Healthcare, LLC will be based in Denver, ... provide new pneumatic tube systems or expand existing systems within the U.S. and ...
Breaking Biology Technology:
(Date:1/20/2016)... MINNETONKA, Minn. , Jan. 20, 2016   ... that supports the entire spectrum of clinical research, is ... in 2015. MedNet,s significant achievements are the result of ... of) iMedNet eClinical , it,s comprehensive, ... --> --> Key MedNet growth ...
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
(Date:1/8/2016)... and MANCHESTER, United Kingdom , ... a developer of innovative sensor-based diagnostic products, today announced the ... by new and existing investors.  Proceeds from the financing will ... Scanner , a hand-held device for detecting early-stage pressure ulcers. ... Ireland after receiving CE Mark approval. The ...
Breaking Biology News(10 mins):